John M. Littleton
Principal investigator.
Biotech
Built from public records only: federal awards, patents, filings and papers.Is this you? Contact Noair Lab to claim this profile, correct it or hide it.
2015First federal award
$5.7MFederal grants as PI12 awards
1Patents grantedLatest Sep 12, 2017
182Papers5,769 citations
Federal awards and patents by year
AwardsPatents
12 awards · $5.7M
| Date | Agency | Award | Amount | Company |
|---|---|---|---|---|
| Aug 13, 2021 | NIH | SBIR Phase II Mimicking synuclein toxicity in plant cells to identify novel neuroprotective leads | $618K | NAPROGENIX, INC. |
| Apr 9, 2021 | NIH | SBIR Phase II Novel modulators of the dopamine transporter for alcohol and nicotine use disorders | $976K | NAPROGENIX, INC. |
| Sep 20, 2020 | NIH | SBIR Phase II Mimicking synuclein toxicity in plant cells to identify novel neuroprotective leads | $624K | NAPROGENIX, INC. |
| Sep 4, 2020 | NIH | SBIR Phase II Novel modulators of the dopamine transporter for alcohol and nicotine use disorders | $140K | NAPROGENIX, INC. |
| Apr 3, 2020 | NIH | SBIR Phase II Novel modulators of the dopamine transporter for alcohol and nicotine use disorders | $890K | NAPROGENIX, INC. |
| Feb 27, 2019 | NIH | SBIR Phase II Mutant transgenic plant cells as a novel source of drugs | $105K | NAPROGENIX, INC. |
| Aug 31, 2018 | NIH | SBIR Phase I Mimicking synuclein toxicity in plant cells to identify novel neuroprotective leads | $231K | NAPROGENIX, INC. |
| Mar 23, 2018 | NIH | SBIR Phase II Harvesting specific plant metabolites from hairy root cultures using magnetized nanoparticles | $499K | NAPROGENIX, INC. |
| Aug 21, 2017 | NIH | SBIR Phase II Mutant transgenic plant cells as a novel source of drugs | $490K | NAPROGENIX, INC. |
| Mar 28, 2017 | NIH | SBIR Phase II Harvesting specific plant metabolites from hairy root cultures using magnetized nanoparticles | $530K | NAPROGENIX, INC. |
| Sep 22, 2016 | NIH | SBIR Phase II Mutant transgenic plant cells as a novel source of drugs | $456K | NAPROGENIX, INC. |
| Mar 23, 2015 | NIH | SBIR Phase II Selection-driven plant metabolites for treatment of CNS diseases | $98K | NAPROGENIX, INC. |
1 patents as inventor
- US 9758788NAPROGENIX, INC.Sep 12, 2017
Matched by the first inventor’s name and the patent’s company.
Peer ranks
Federal funding#215
Awards as PI#86
Patents#155
Companies
- NAPROGENIX, INC.Linked by awards · Biotech
Federal awards through Oct 21, 2026 and patents through Oct 20, 2026. Awards come from NIH, NSF and other agency records that name a principal investigator; DoD and NASA contract awards do not, so they are not shown here. Researchers are matched by name and company.